"False"
Umeå University
printicon
Main menu hidden.

Malin Boremalm

Contact

E-mail
malin.boremalm@umu.se
Phone

Works at

Affiliation
Affiliated as other position at Department of Clinical Sciences Section: Neurosciences
Location
Norrlands universitetssjukhus, Umeå universitet, Klinisk vetenskap Umeå universitet, Klinisk vetenskap, 901 85 Umeå
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis
Journal of Neurology, Springer 2021, Vol. 268, (6) : 2161-2168
Boremalm, Malin; Sundström, Peter; Salzer, Jonatan
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
European Journal of Neurology, Vol. 26, (8) : 1060-1067
Boremalm, Malin; Juto, A.; Axelsson, M.; et al.
Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis
Multiple Sclerosis Journal, Sage Publications 2019, Vol. 25 : 20-20
Hallberg, S.; Boremalm, Malin; Evertsson, B.; et al.
Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
JAMA Neurology, American Medical Association 2018, Vol. 75, (3) : 320-327
Granqvist, Mathias; Boremalm, Malin; Poorghobad, Amyar; et al.
View publications in DiVA